Product
DUOC-01
2 clinical trials
16 indications
Indication
Primary Progressive Multiple SclerosisIndication
AdrenoleukodystrophyIndication
Batten DiseaseIndication
MPS IIIndication
leukodystrophyIndication
Krabbe DiseaseIndication
MetachromaticIndication
Niemann-Pick DiseaseIndication
Pelizaeus-Merzbacher DiseaseIndication
Sandhoff diseaseIndication
Tay-Sachs DiseaseIndication
Brain DiseasesIndication
MetabolicIndication
InbornIndication
alpha-mannosidosisIndication
Mucopolysaccharidosis IIIClinical trial
Phase IA Trial of Intrathecal Administration of Human Umbilical Cord Blood-Derived Cell Therapy (DUOC-01) in Adults With Primary Progressive Multiple Sclerosis (PPMS)Status: Recruiting, Estimated PCD: 2025-08-30
Clinical trial
Augmentation of Umbilical Cord Blood Transplantation for Inherited Metabolic Diseases With Intrathecal Administration of Human Umbilical Cord Blood-Derived Oligodendrocyte-Like CellsStatus: Recruiting, Estimated PCD: 2024-10-01